Overcoming Barriers In Cell-Based Cancer Therapy
Universal, off‑the‑shelf CAR‑T cell therapies using gene‑edited donor T cells are beginning to overcome key barriers of cost, delay and access in cell‑based cancer treatment. Valueinvestor on Freepik One of the most dramatic improvements in cancer therapy over the past several years has been the adoption of cell-based therapies. Many of these involve CAR T … Read more